Notify me when Contrarius Investment Management Ltd files a new Schedule 13D/G report.
⭐ Subscribe ⭐| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| QVCGA | QVC GROUP, INC. | SERIES A COMMON STOCK | 8.9% | $6,472,493 | 702,768 | 0% | Contrarius Investment Management Ltd | 31 Dec 2025 | |
| QVCGA | QVC Group, Inc. | SERIES A COMMON STOCK | 8.9% | $5,270,777 | 35,138,516 | 0% | Contrarius Investment Management Ltd | 31 Mar 2025 | |
| NTLA | INTELLIA THERAPEUTICS, INC | COMMON STOCK | 0.6% | $8,166,506 | -$59,155,462 | 714,480 | -88% | Contrarius Investment Management Ltd | 31 Dec 2025 |
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Filing Date |
|---|